Mouse CCND2 Antibody (C-term T279/T280) western blot analysis in mouse NIH-3T3 cell line lysates (35ug/lane).This demonstrates the Mouse CCND2 antibody detected the Mouse CCND2 protein (arrow).
Regulatory component of the cyclin D2-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D2/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex (By similarity)
Tissue Specificity
This Mouse CCND2 Antibody Antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 265-289 amino acids from the C-term region of mouse CCND2.
Cellular Localization
Nucleus (By similarity). Cytoplasm (By similarity). Membrane (By similarity). Note=Cyclin D-CDK4 complexes accumulate at the nuclear membrane and are then translocated into the nucleus through interaction with KIP/CIP family members (By similarity)
Mouse CCND2 Antibody (C-term T279/T280) western blot analysis in mouse NIH-3T3 cell line lysates (35ug/lane).This demonstrates the Mouse CCND2 antibody detected the Mouse CCND2 protein (arrow).
Application Notes
WB:1:100~500
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.